Portfolio

ABO COMMITS TO A BETTER FUTURE

Our investments

+80

"PIPE" investments

Since the creation of the group in 2017

+60

Convertible securities

Since the creation of the group in 2017

2B

2 Milliard de dollars

Total funding commitments

20M

20 million dollars

Average amount of commitments

17

17 pays

A broad geographical investment mandate

Our selected Deals

netweek

Endurance

3 150 000 EUR

Convertible Bonds

June 2023

netweek

Netweek

15 000 000 EUR

Convertible Bonds

November 2022

tetra bio pharma

Tetra Bio-Pharma

10 000 000 CAD

Convertible Bonds

September 2022

transcanna

TransCanna

9 500 000 CAD

Convertible Bonds

August 2022

Neolife II

2 000 000 EUR

Convertible Bonds

July 2022

Bone Therapeutics

Bone Therapeutics

5 000 000 EUR

Convertible Bonds

May 2022

Pharmasimple II

200 000 000 EUR

Convertible Bonds

May 2022

Vergnet

6 000 000 EUR

Convertible Bonds

April 2022

Halo Collective II

65 000 000 CAD

Convertible Bonds

March 2022

DBT II

50 000 000 EUR

Convertible Bonds

February 2022

Intercity C.F

400 000 EUR

Equity

February 2022

Intercity C.F

4 500 000 EUR

Convertible Bonds

February 2022

NFTY

3 000 000 EUR

Convertible Bonds

January 2022

Halo Collective

14 000 000 CAD

Unsecured loan

January 2022

Safe Ortopaedics III

8 000 000 EUR

Convertible Bonds

December 2021

Europlasma V

100 000 000 EUR

Convertible Bonds

April 2021

LTBM

5 000 000 EUR

Convertible Bonds

October 2021

Pharmasimple

10 000 000 EUR

Convertible Bonds

September 2021

Neovacs II

50 000 000 EUR

Convertible Bonds

September 2021

Pharnext

81 000 000 EUR

Convertible Bonds

June 2021

Wilton Resources

4 500 000 SGD

Convertible Bonds

March 2021

ADL Bionatur

5 000 000 EUR

Convertible Bonds

March 2021

Europlasma IV

6 500 000 EUR

Debt Restructuring

April 2021

WISeKey

15 500 000 CHF

Convertible Bonds

December 2020

Safe Orhtopaedics II

8 400 000 EUR

Convertible Bonds

December 2020

AB Science

4 000 000 d’actions

Programme d’augmentation de capital à terme

November 2020

Imvest

6 000 000 EUR

Convertible Bonds

July 2020

Erytech

60 000 000 EUR

Convertible Bonds

June 2020

Voluntis

10 000 000 EUR

Convertible Bonds

March 2020

DBT

12 250 000 EUR

Convertible Bonds

February 2020

Infoscan

21 000 000 PLN

Convertible Bonds

June 2019

Europlasma III

30 000 000 EUR

Convertible Bonds

June 2019

Safe Orthopaedics

12 450 000 EUR

Convertible Bonds

May 2019

Braster

42 500 000 PLN

Convertible Bonds

March 2019

Ecorub

20 000 000 SEK

Convertible Bonds

October 2018

Intrasense

3 500 000 EUR

Convertible Bonds

August 2018

Europlasma II

8 000 000 EUR

Convertible Bonds

July 2018

Spineway

14 500 000 EUR

Convertible Bonds

July 2018

Cereno Scientific

40 000 000 SEK

Convertible Bonds

March 2018

Europlasma

8 000 000 EUR

Convertible Bonds

February 2018

Neolife

5 000 000 EUR

Convertible Bonds

December 2017

Obducat

35 000 000 SEK

Convertible Bonds

October 2017

Auplata

60 000 000 EUR

Convertible Bonds

October 2017

They talk about us

Alpha Blue Ocean

Testimonials

More than a financial partner, ABO team is well organised to support the expansion of Safe group since 2019. Thanks to a sharp sense of analysis and a deep trust in the company, ABO contributed to the integration of the  value chain by acquiring a company in the middle of the covid crisis, which changed the size of the group.

François-Henri Reynaud

CFO and board member of Safe Group

Alpha Blue Ocean has been a great strategic partner helping us achieve our goals by acquiring relevant assets through their flexible alternative financing offerings. We’re grateful of having a financial partner of the sort who’s wide expertise and network can help us beyond financing our core business, but also by connecting us to relevant businesses and persons in the industry to provide relevant synergies.

Carlos Moreira, CEO of WISeKey

en_GBEnglish